LENZ Therapeutics (LENZ) Institutional Ownership $23.49 -1.45 (-5.81%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$23.46 -0.02 (-0.11%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for LENZ Therapeutics (NASDAQ:LENZ)CurrentInstitutional OwnershipPercentage54.32%Number ofInstitutional Buyers(last 12 months)52TotalInstitutional Inflows(last 12 months)$163.89MNumber ofInstitutional Sellers(last 12 months)15TotalInstitutional Outflows(last 12 months)$13.50M Get LENZ Insider Trade Alerts Want to know when executives and insiders are buying or selling LENZ Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LENZ Institutional Buying and Selling by Quarter LENZ Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/18/2025 Delta Investment Management LLC19,241$555K0.1%N/A0.070% 2/17/2025 Vivaldi Capital Management LP56,252$1.62M0.2%-4.3%0.205% 2/17/2025 Two Sigma Investments LP17,079$493K0.0%-33.0%0.062% 2/17/2025 Rafferty Asset Management LLC17,716$511K0.0%N/A0.064% 2/17/2025 Point72 Asset Management L.P.783,921$22.63M0.0%-9.4%2.851% 2/17/2025 Paradigm Biocapital Advisors LP770,455$22.24M0.8%N/A2.802% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.7,914$229K0.0%+14.5%0.029% 2/17/2025 Granahan Investment Management LLC51,842$1.50M0.1%N/A0.189% 2/17/2025 Deutsche Bank AG9,723$281K0.0%+81.6%0.035% 2/17/2025 D. E. Shaw & Co. Inc.7,447$215K0.0%N/A0.027% Get the Latest News and Ratings for LENZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LENZ Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Bank of America Corp DE38,246$1.10M0.0%+92.7%0.139% 2/17/2025 BNP Paribas Financial Markets1,789$52K0.0%-32.4%0.007% 2/17/2025 Ameriprise Financial Inc.48,088$1.39M0.0%-26.0%0.175% 2/17/2025 Alyeska Investment Group L.P.142,113$4.10M0.0%+16.4%0.517% 2/14/2025 Jane Street Group LLC7,938$229K0.0%-34.0%0.029% 2/14/2025 Samsara BioCapital LLC986,981$28.49M3.9%-18.3%3.589% 2/14/2025 Northern Trust Corp139,288$4.02M0.0%+7.4%0.507% 2/14/2025 The Manufacturers Life Insurance Company 67,891$1.96M0.0%+116.8%0.247% 2/14/2025 Boothbay Fund Management LLC39,746$1.15M0.0%-26.9%0.145% 2/14/2025 Virtus ETF Advisers LLC2,309$67K0.0%N/A0.008% 2/14/2025 Price T Rowe Associates Inc. MD822,957$23.76M0.0%+83.4%2.993% 2/14/2025 Rock Springs Capital Management LP29,305$846K0.0%N/A0.107% 2/14/2025 Tower Research Capital LLC TRC 1,860$54K0.0%+162.3%0.007% 2/13/2025 Barclays PLC30,057$867K0.0%+82.6%0.109% 2/13/2025 Raymond James Financial Inc.8,485$245K0.0%N/A0.031% 2/13/2025 Renaissance Technologies LLC25,366$732K0.0%-48.5%0.092% 2/13/2025 Legal & General Group Plc8,742$252K0.0%+703.5%0.032% 2/13/2025 Wells Fargo & Company MN7,504$217K0.0%+27.3%0.027% 2/12/2025 Geode Capital Management LLC334,026$9.65M0.0%-1.2%1.215% 2/12/2025 Alliancebernstein L.P.7,586$219K0.0%-18.8%0.028% 2/12/2025 Wellington Management Group LLP28,216$815K0.0%+14.6%0.103% 2/12/2025 JPMorgan Chase & Co.8,342$241K0.0%+46.4%0.030% 2/11/2025 Corebridge Financial Inc.6,245$180K0.0%-7.0%0.023% 2/11/2025 Vanguard Group Inc.1,178,447$34.02M0.0%+5.3%4.285% 2/11/2025 KLP Kapitalforvaltning AS1,600$46K0.0%N/A0.006% 2/11/2025 American Century Companies Inc.32,506$938K0.0%+36.2%0.118% 2/10/2025 Swiss National Bank18,900$546K0.0%N/A0.069% 2/7/2025 BML Capital Management LLC9,271$268K0.2%-84.5%0.034% 2/6/2025 Raymond James Financial Inc.8,485$245K0.0%N/A0.031% 2/6/2025 Charles Schwab Investment Management Inc.127,196$3.67M0.0%+3.1%0.463% Elon’s “New Gold” (Ad)MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.I reveal all of the details here.2/4/2025 Bank of New York Mellon Corp29,214$843K0.0%-1.4%0.106% 1/30/2025 Rhumbline Advisers18,754$541K0.0%+6.2%0.068% 1/27/2025 Mirae Asset Global Investments Co. Ltd.916$29K0.0%N/A0.003% 1/24/2025 China Universal Asset Management Co. Ltd.5,831$168K0.0%N/A0.021% 1/17/2025 SG Americas Securities LLC5,458$158K0.0%+20.7%0.020% 1/17/2025 Kelleher Financial Advisors17,023$491K0.2%-18.1%0.062% 1/10/2025 Harbor Capital Advisors Inc.43,989$1.27M0.1%N/A0.160% 11/19/2024 Barclays PLC16,463$391K0.0%+273.1%0.060% 11/16/2024 Geode Capital Management LLC338,024$8.03M0.0%-6.1%1.229% 11/15/2024 Barclays PLC16,463$391K0.0%+273.1%0.060% 11/15/2024 Jane Street Group LLC12,027$286K0.0%N/A0.044% 11/15/2024 Wellington Management Group LLP24,621$585K0.0%N/A0.090% 11/15/2024 State Street Corp289,154$6.87M0.0%+18.7%1.051% 11/15/2024 Parkman Healthcare Partners LLC139,357$3.31M0.4%N/A0.507% 11/14/2024 BBR Partners LLC40,000$950K0.1%+100.0%0.145% 11/14/2024 MetLife Investment Management LLC7,672$182K0.0%N/A0.028% 11/13/2024 BNP Paribas Financial Markets2,648$63K0.0%-83.9%0.010% 11/13/2024 The Manufacturers Life Insurance Company31,309$743K0.0%N/A0.114% 11/12/2024 Charles Schwab Investment Management Inc.123,371$2.93M0.0%+197.5%0.449% 11/5/2024 BML Capital Management LLC60,000$1.42M0.8%-6.1%0.218% 11/5/2024 GSA Capital Partners LLP10,357$246K0.0%N/A0.038% 10/3/2024 SG Americas Securities LLC4,523$107K0.0%N/A0.124% 8/15/2024 Deerfield Management Company L.P. Series C17,353$300K0.0%N/A0.476% 8/14/2024 Squarepoint Ops LLC10,477$181K0.0%N/A0.287% 8/14/2024 Marshall Wace LLP22,554$390K0.0%N/A0.618% 8/9/2024 Renaissance Technologies LLC60,166$1.04M0.0%+28.4%1.649% 8/9/2024 Dimensional Fund Advisors LP37,190$644K0.0%+58.0%1.019% 8/5/2024 BBR Partners LLC20,000$346K0.0%N/A0.548% 8/1/2024 Rhumbline Advisers16,812$291K0.0%+265.6%0.461% 7/26/2024 Bank of New York Mellon Corp39,737$687K0.0%+255.4%1.089% 7/16/2024 Wealth Enhancement Advisory Services LLC83,103$1.44M0.0%N/A2.277% 5/17/2024 RA Capital Management L.P.4,178,823$93.31M1.2%N/A114.488% 5/17/2024 Ikarian Capital LLC85,000$1.90M0.2%N/A2.329% 5/16/2024 Jacobs Levy Equity Management Inc.37,176$830K0.0%N/A1.019% 5/14/2024 American International Group Inc.1,973$44K0.0%N/A0.054% 5/10/2024 Vanguard Group Inc.206,952$4.62M0.0%N/A5.670% 5/7/2024 Marquette Asset Management LLC5,865$131K0.0%N/A0.161% 5/2/2024 Jennison Associates LLC134,740$3.01M0.0%N/A3.692% 5/1/2024 BNP Paribas Financial Markets16,221$362K0.0%N/A0.444% 4/25/2024 BML Capital Management LLC63,916$1.43M0.9%N/A1.751% (Data available from 1/1/2016 forward) LENZ Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LENZ shares? During the previous two years, 62 institutional investors and hedge funds held shares of LENZ Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($93.31M), Vanguard Group Inc. ($34.02M), Samsara BioCapital LLC ($28.49M), Price T Rowe Associates Inc. MD ($23.76M), Point72 Asset Management L.P. ($22.63M), Paradigm Biocapital Advisors LP ($22.24M), and Geode Capital Management LLC ($9.65M).Learn more on LENZ's institutional investors. What percentage of LENZ Therapeutics stock is owned by institutional investors? 54.32% of LENZ Therapeutics stock is owned by institutional investors. Learn more on LENZ's institutional investor holdings. Which institutional investors have been buying LENZ Therapeutics stock? Of the 52 institutional investors that purchased LENZ Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($4.18M), Paradigm Biocapital Advisors LP ($770.46K), Price T Rowe Associates Inc. MD ($374.33K), Vanguard Group Inc. ($266.58K), Parkman Healthcare Partners LLC ($139.36K), Jennison Associates LLC ($134.74K), and Charles Schwab Investment Management Inc. ($85.73K). How much institutional buying is happening at LENZ Therapeutics? Institutional investors have bought a total of 6,908,559 shares in the last 24 months. This purchase volume represents approximately $163.89M in transactions. Which LENZ Therapeutics major shareholders have been selling company stock? Of the 15 institutional investors that sold LENZ Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Samsara BioCapital LLC ($221.49K), Point72 Asset Management L.P. ($81.02K), BML Capital Management LLC ($54.65K), Geode Capital Management LLC ($26.09K), Renaissance Technologies LLC ($23.90K), Ameriprise Financial Inc. ($16.85K), and BNP Paribas Financial Markets ($14.68K). How much institutional selling is happening at LENZ Therapeutics? Institutional investors have sold a total of 474,745 shares in the last 24 months. This volume of shares sold represents approximately $13.50M in transactions. Related Companies MLTX Institutional Ownership MRUS Institutional Ownership BEAM Institutional Ownership IBRX Institutional Ownership ARWR Institutional Ownership HCM Institutional Ownership EWTX Institutional Ownership MIRM Institutional Ownership AMRX Institutional Ownership KYMR Institutional Ownership This page (NASDAQ:LENZ) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENZ Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENZ Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LENZ Stock Alerts